27 September 2018
14 September 2018
The MENA Community Advisory Board (MENA-CAB) 2017 Report
The Community Advisory Board (CAB) constitutes a space of exchange between advocates from the MENA region, researchers and drug manufacturers, with the aim to educate people living with HIV and their advocates on access
29 June 2018
HRC38: Human Rights Council set to adopt resolution on Human rights in the context of…
On Thursday, 28 June 2018, the delegations of Brazil, Colombia, Mozambique, Portugal, and Thailand submitted a draft resolution on “Human rights in the context of HIV and AIDS” to the 38th session of the
16 February 2018
Civil Society Speaks: Fighting for Universal Access To Dolutegravir (DTG)!
Source : The Global Network of People living with HIV GNP+ What do people living with HIV need to know about Dolutegravir? What do our communities need to know about viral resistance to first
8 February 2018
Global Fund MENA Regional Platform is relaunched
ITPC-MENA continues as the host for the Middle East and North Africa region As a key component of the Global Fund’s Community, Rights and Gender Strategic Initiative, the Regional Platform for Communication and Coordination
26 October 2017
New Study : Assessment of national intellectual property landscapes and their impact …
Title: A tool to assess how friendly to access-to-medicines your law is Background Provisions of intellectual property (IP) may have an important impact on access to medicines. For instance, the monopoly granted by the
19 September 2017
Job offer for the MENA regional platform manager on Global Fund and Civil Society
JOB DESCRIPTION: REGIONAL GLOBAL FUND PLATFORM MANAGER ABOUT ITPC-MENA: International Treatment Preparedness Coalition (ITPC) Middle East & North Africa (MENA) is a regional non governmental organization operating in the Middle East and North Africa
26 July 2017
IAS 2017: Closing ceremony exposes Gilead Sciences
Conference funders, Gilead Sciences, named and shamed for its “insatiable greed” Yesterday, the 9th International AIDS Conference on HIV Science in Paris (IAS 2017), drew to a close, in style. The community address delivered
25 July 2017
A new victory for ITPC-MENA : Bristol-Myers Squibb extends its voluntary license on A…
The 9th International AIDS Society Conference on HIV / AIDS 2017 : Bristol-Myers Squibb extends its voluntary license on Atazanavir to Egypt, a victory for ITPC-MENA Today, at the World Conference on AIDS, which
25 July 2017